In the latest twist in the saga pitting sovereign immunity against inter partes review, the PTAB issued a decision on December 19, 2017 that potentially jams a spoke into the wheels of future partnerships between brand pharma and Tribes. What does this decision bode for Allergan’s Restasis® deal with the St. Regis Mohawk Tribe? What are the consequences of this decision?
Read More